Home > Browse Research > Life Sciences > Pharmaceuticals > Research & Development

Research & Development: market research reports

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce.

In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

Research & Development market research reports and industry analysis

The World Market for Orphan Drugs 6/13/2013 \| published by: Kalorama Information ... estimates for the market opportunity in the U.S., Europe, Japan and globally. With over 400 pages of market analysis and over 120 figures and tables, the report provides in-depth coverage of key competitors and important ... \| read more...	$4,500.00
Analytical Tool - Melanoma 6/12/2013 \| published by: BioSeeker Group AB ... research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. ... \| read more...	$4,650.00
Melanoma Drug Development Analysis: From First-in-Class to Best-in-Class? 6/12/2013 \| published by: BioSeeker Group AB ... setting the path? What is first-in-class in the melanoma pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and how? Locate the right drugs to benchmark against ... \| read more...	$2,925.00
Global Markets for Orphan Drugs – Focus on Biologics 6/1/2013 \| published by: BCC Research ... Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017. Detailed discussion of successful orphan products. Detailed analysis of blockbuster orphan drugs. The rising ... \| read more...	$4,400.00
Global Markets for Orphan Drugs – Focus on Non-Biologics 6/1/2013 \| published by: BCC Research ... Analyses of global market trends, with data from 2010 to 2012, and projections of compound annual growth rates (CAGRs) through 2017. Detailed discussion of successful orphan products. Detailed analysis of blockbuster orphan drugs. The rising ... \| read more...	$4,400.00
Global Markets for Orphan Drugs 6/1/2013 \| published by: BCC Research ... data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017 Detailed discussion of successful orphan products Detailed analysis of blockbuster orphan drugs The rising influence of pharmacogenomics in the orphan ... \| read more...	$5,450.00
Dental Pain – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Dental Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Pain. Dental Pain - Pipeline Review, Half Year ... \| read more...	$2,000.00
EpiCast Report: Asthma - Epidemiology Forecast to 2022 5/27/2013 \| published by: GlobalData ... et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in the general population varied widely in different countries around the world, with proportions ranging between 1% in Albania ... \| read more...	$3,995.00
Anti Peptic Ulcer Drugs Markets in China 5/25/2013 \| published by: Asia Market Information & Development Company ... continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term ... \| read more...	$2,000.00
Global Alzheimer's Drugs Market 2012-2016 5/24/2013 \| published by: Infiniti Research Limited ... The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market. TechNavio's report, the Global Alzheimer's Drugs market ... \| read more...	$2,500.00
Infectious Diseases in Europe: Market Segment Forecasts and Supplier Shares 5/20/2013 \| published by: Venture Planning Group ... companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses ... \| read more...	$19,700.00
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi 5/20/2013 \| published by: Access China Management Consulting Ltd. ... a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not been clearly described by the modern medical terminologies. How the Chinese drug authorities to administer the ... \| read more...	$750.00
The World Market for Pain Management Drugs and Devices 5/20/2013 \| published by: Kalorama Information ... as a result, the range of therapeutic options available to physicians and other clinicians has expanded. Solutions to pain disorders are still elusive but continued human and animal studies will help to further identify the ... \| read more...	$3,500.00
Conference Documentation: ADC Summit 2013 5/20/2013 \| published by: SMI Publishing, Ltd ... of targeted chemotherapy for the treatment of cancer. Anticipated use of ADCs over the next 5-10 years in set to increase by 40-50% specifically within cancer research. This huge surge in programme is down to ... \| read more...	$788.78
Conference Documentation: Pain Therapeutics 5/20/2013 \| published by: SMI Publishing, Ltd ... conference which will highlight improvements in R&D methods and certifying that drugs being put forward for clinical trials are given the best chance to succeed. The conference will take place on the 20th and 21st ... \| read more...	$788.78
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016 5/19/2013 \| published by: Infiniti Research Limited ... increase in prevalence of the MRSA infection. The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market has also been witnessing the increase in Governmental/Non-Governmental awareness programs. However, the increasing generic competition could pose a challenge to ... \| read more...	$2,500.00
Global Melanoma Therapeutics Market 2012-2016 5/17/2013 \| published by: Infiniti Research Limited ... promising drugs in the pipeline. The Global Melanoma Therapeutics market has also been witnessing the increasing use of combination therapies for the treatment of melanoma. However, the availability of alternative treatment options could pose a ... \| read more...	$2,000.00
US Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers 5/16/2013 \| published by: Venture Planning Group ... market impact during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed ... \| read more...	$9,850.00
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players 5/15/2013 \| published by: GlobalData ... up-to-date information with in-depth analysis on the companies in the rapidly growing CML Market. The report identifies and analyses the key companies shaping and driving the global CML market. The report provides insight into the ... \| read more...	$2,995.00
Orphan Drugs in Oncology Drug Pipeline Update 2013 5/14/2013 \| published by: BioSeeker Group AB ... are being granted orphan drug status, but also detailed insights in to their mechanism of action and developmental strategy. The orphan drug designation is designed to promote the development of drugs that may provide significant ... \| read more...	$2,249.00
China Pharmaceutical Guidebook Series (3) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products 5/10/2013 \| published by: Access China Management Consulting Ltd. ... behind the developed countries. The requirements of materials and clinical trials for registration application of biopharmaceuticals stipulated by the Chinese pharmaceutical authority are far from systematic and harmonized. In China, the pharmaceutical regulatory authority ----- ... \| read more...	$750.00
Antibiotics Partnering Agreements - CP2119 - May2013v1 5/1/2013 \| published by: Current Partnering ... royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value The Antibiotics Partnering Terms and Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into ... \| read more...	$1,795.00
Hypertension Treatment Drugs Markets in China 5/1/2013 \| published by: Asia Market Information & Development Company ... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers ... \| read more...	$2,000.00
Anti-Obesity Drugs Markets in China 5/1/2013 \| published by: Asia Market Information & Development Company ... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in ... \| read more...	$2,000.00
Osteoporosis Treatment Drugs Markets in China 5/1/2013 \| published by: Asia Market Information & Development Company ... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers ... \| read more...	$2,000.00

< prev 1 2 3 4 5 6 7 8 9 10 next >